MARATTO

article · Kidney International Reports

WCN26-7886 RENAL ADVERSE EFFECTS OF ANTI-ANGIOGENIC AGENTS IN A TERTIARY HOSPITAL IN KENYA

Abstract

nephropathy, including M-type phospholipase A2 receptor (PLA2R), were negative.Electron microscope showed subepithelial electrondense deposits.Based on these findings, a diagnosis of anti-GBM nephritis concurrent with MN was established.Following the addition of fourteen sessions of plasma exchange to the immunosuppressive therapy, the titer of anti-GBM antibody decreased to 4.8 U/mL; however, kidney function failed to recover, and the patient remained dialysis dependent.Conclusion: Discussion: This patient presented with rapidly progressive glomerulonephritis and severe proteinuria.Kidney biopsy demonstrated crescentic anti-GBM glomerulonephritis with MN, based on both linear and granular deposition of IgG and C3 on immunofluorescence and subepithelial electron-dense deposits on electron microscopy.Identification of the specific target antigens (e.g., PLA2R, NELL1, THSD7A, EXT1/2) may confirm primary and secondary MN and assist in guiding appropriate therapeutic approaches.Furthermore, recent reports have shown that MPO immunostaining may be useful in diagnosing MN secondary to MPO-ANCA-associated vasculitis.In this case, we postulated that MN might have preceded and subsequently induced the formation of anti-GBM antibodies.However, these antigen stains were all negative.Nevertheless, these antigen-based analysis provide valuable insight into the underlying pathophysiology.The coexistence of anti-GBM nephritis and MN with MPO-ANCA positivity is exceptionally uncommon, and the clinical relevance of this association warrant further investigation.This work was first presented at ASN Kidney Week 2025, and re-submission is permitted by ASN.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Research topics

  • Renal Transplantation Outcomes and Treatments
  • Chronic Kidney Disease and Diabetes
  • Acute Kidney Injury Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.ekir.2026.104022

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.